Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived cardiomyocytes and preclinical drug screening

Ibrahim El‐Battrawy(University Hospitals of the Ruhr-University of Bochum), Xiaobo Zhou(Heidelberg University), Xuehui Fan(Heidelberg University), Boldizsar Kovacs(University of Michigan), Zhenxing Liao(Heidelberg University), Jonas Müller(Friedrich-Alexander-Universität Erlangen-Nürnberg), Alyssa Hohn(Heidelberg University), Ardan M. Saguner(University of Zurich), Rujia Zhong(Heidelberg University), Hendrik Dinkel(Heidelberg University), Assem Aweimer(BG University Hospital Bergmannsheil Bochum), Siegfried Lang(Heidelberg University), İbrahim Akın(University of Mannheim), Andreas Mügge(Roche (Switzerland)), Fırat Duru(University of Malta), Lasse Maywald(Heidelberg University), Eliane Duperrex, Lukas Cyganek(Institute of Molecular Bioimaging and Physiology), Yingrui Li(BGI Group (China)), Mandy Kleinsorge(Universitätsmedizin Göttingen), Sebastian Diecke(Max Delbrück Center), Sebastian Albers(Heidelberg University), Lena Rose(Heidelberg University), Feng Zhang(Heidelberg University), Guang Li(Guangdong Medical College), Ji‐Hyun Lee(Gachon University), Zhen Yang(Heidelberg University), Qiao Lin(China Medical University), Qiang Xu(Wannan Medical College), Andreas Hierlemann(ETH Zurich), Huan Lan(Southwest Medical University), Mengying Huang(Heidelberg University)
Clinical and Translational Medicine
December 1, 2021
Cited by 22


Related Papers